Polscope Sperm: A Non-invasive Method to Assess DNA Damage in Individual Sperm
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01461395 |
Recruitment Status :
Completed
First Posted : October 28, 2011
Last Update Posted : August 24, 2012
|
Sponsor:
University of South Florida
Information provided by (Responsible Party):
University of South Florida
Tracking Information | ||||
---|---|---|---|---|
First Submitted Date | February 2, 2011 | |||
First Posted Date | October 28, 2011 | |||
Last Update Posted Date | August 24, 2012 | |||
Study Start Date | October 2008 | |||
Actual Primary Completion Date | June 2012 (Final data collection date for primary outcome measure) | |||
Current Primary Outcome Measures | Not Provided | |||
Original Primary Outcome Measures | Not Provided | |||
Change History | ||||
Current Secondary Outcome Measures | Not Provided | |||
Original Secondary Outcome Measures | Not Provided | |||
Current Other Pre-specified Outcome Measures | Not Provided | |||
Original Other Pre-specified Outcome Measures | Not Provided | |||
Descriptive Information | ||||
Brief Title | Polscope Sperm: A Non-invasive Method to Assess DNA Damage in Individual Sperm | |||
Official Title | A Non-invasive Method to Assess DNA Damage in Individual Sperm | |||
Brief Summary | The purpose of this study is to find a non-invasive way to discover DNA (deoxyribonucleic acid, which is the genetic material inside your cells) alterations in the sperm's head, in the near future leading us to choose the "good sperm" in a simplified manner. This could then increase chances of a successful in-vitro fertilization (IVF) treatment when there are sperm abnormalities. | |||
Detailed Description | If you take part in this study,
|
|||
Study Type | Observational | |||
Study Design | Observational Model: Cohort Time Perspective: Prospective |
|||
Target Follow-Up Duration | Not Provided | |||
Biospecimen | Retention: Samples With DNA Description: sperm
|
|||
Sampling Method | Non-Probability Sample | |||
Study Population | IVF patients already undergoing therapy and providing a semen sample for sperm count | |||
Condition |
|
|||
Intervention | Not Provided | |||
Study Groups/Cohorts | Not Provided | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||
Recruitment Information | ||||
Recruitment Status | Completed | |||
Actual Enrollment |
84 | |||
Original Estimated Enrollment |
100 | |||
Actual Study Completion Date | June 2012 | |||
Actual Primary Completion Date | June 2012 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria: -unable to provide informed consent |
|||
Sex/Gender |
|
|||
Ages | 18 Years to 60 Years (Adult) | |||
Accepts Healthy Volunteers | Yes | |||
Contacts | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries | United States | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number | NCT01461395 | |||
Other Study ID Numbers | 107209 | |||
Has Data Monitoring Committee | Yes | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement | Not Provided | |||
Responsible Party | University of South Florida | |||
Study Sponsor | University of South Florida | |||
Collaborators | Not Provided | |||
Investigators |
|
|||
PRS Account | University of South Florida | |||
Verification Date | August 2012 |